The emergence of “lifestyle medicine” as a structured approach for management of chronic disease

Garry J Egger, Andrew F Binns and Stephan R Rossner
Med J Aust 2009; 190 (3): 143-145.
  • Garry J Egger1,2
  • Andrew F Binns2,3
  • Stephan R Rossner4

  • 1 Centre for Health Promotion Research, Sydney, NSW.
  • 2 Southern Cross University, Lismore, NSW.
  • 3 Lismore, NSW.
  • 4 Karolinska Institute, Stockholm, Sweden.


Competing interests:

Garry Egger coordinates and Andrew Binns has contributed to a postgraduate Master of Clinical Science (Lifestyle-Medicine) program through Southern Cross University. Andrew Binns is the president of ALMA and Garry Egger is an ALMA committee member.

  • 1. Australian Institute of Health and Welfare. Chronic diseases and associated risk factors in Australia, 2006. Canberra: AIHW, 2006. (AIHW Cat. No. PHE 81.)
  • 2. Australia 2020 Summit: long-term health strategy. (accessed Nov 2008).
  • 3. Rose G. The strategy of preventive medicine. Oxford: Oxford University Press, 1992.
  • 4. Egger G, Binns A, Rossner S. Lifestyle medicine. Sydney: McGraw-Hill Australia, 2008.
  • 5. Rippe J, editor. Lifestyle medicine. New York: Blackwell, 1999.
  • 6. Australian Government Department of Health and Ageing. Enhanced Primary Care Program (EPC). (accessed Nov 2008).
  • 7. Beilby JJ. Primary care reform using a layered approach to the Medicare Benefits Scheme: unpredictable and unmeasured. Med J Aust 2007; 187: 69-71. <MJA full text>
  • 8. Egger G. Personal carbon trading: a potential “stealth intervention” for obesity reduction? Med J Aust 2007; 187: 185-187. <MJA full text>
  • 9. Herder C, Peltonen M, Koenig W, et al. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Diabetes 2006; 55: 2340-2346.
  • 10. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008; 371: 1783-1789.
  • 11. Haffner S, Temprosa M, Crandall J, et al; Diabetes Prevention Program Research Group. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 2005; 54: 1566-1572.
  • 12. Galani C, Schneider H, Rutten FF. Modelling the lifetime costs and health effects of lifestyle intervention in the prevention and treatment of obesity in Switzerland. Int J Public Health 2007; 52: 372-382.
  • 13. Miller WR, Rollnick S. Motivational interviewing: preparing people for change. London: Guilford Press, 2002.
  • 14. Barbour KA, Edenfield TM, Blumenthal JA. Exercise as a treatment for depression and other psychiatric disorders: a review. J Cardiopulm Rehabil Prev 2007; 27: 359-367.
  • 15. Hotamisligil GS. Inflammation and metabolic disease. Nature 2006; 444: 860-867.
  • 16. Sinzinger H, O’Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Brit J Clin Pharmacol 2004; 57: 525-528.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.